The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut.
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
In 2006, Yale New Haven Hospital broke ground for the new cancer hospital, scheduled to open in 2009.
In 2005, The Connecticut Challenge Survivorship Clinic was established at Yale Cancer Center providing the first specialized resource…
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
In 2003, Yale Cancer Center partnered with the National Cancer Institute to create the first cooperative training program…
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
In 1990, Connecticut United for Research Excellence Inc. (CURE) was founded. CURE was a statewide coalition of educational…
In 1989, Connecticut Innovations (CI), created by the Connecticut Legislature, provides strategic capital and operational support to advanced…
In 1988, oncologists from Yale Cancer Center performed the first bone marrow transplant in Connecticut at the Yale-New…
In 1982, the U.S. Centers for Disease Control and Prevention (CDC) launched a national surveillance for tick-borne Lyme…
In 1981, Frank Ruddle from Yale University, Frank Costantini and Elizabeth Lacy from Oxford, and Ralph L. Brinster…
In 1979, Joan Steitz discovered snRNPs, RNAï¾–protein complexes in the cell’s nucleus that perform a crucial step in…
In 1976, the National Cancer Institute established a Cancer Information Service office at Yale Cancer Center to serve…
In 1975, Lyme Disease was identified and named at Yale University. The spirochete that causes Lyme disease was…
In 1975, Lyme disease, an inflammatory disease caused by Gram-negative spirochetal bacteria and spread through a tick bite,…
In 1974, George E. Palade, of the Yale University School of Medicine, was awarded the 1974 Nobel Prize…
In 1974, Yale Cancer Center (YCC) was founded , bringing together the resources of Yale Medicine, Smilow Cancer…
In 1974, Yale Cancer Center received NCI designated comprehensive cancer center status, the only such designated center in…
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…
In 1963, Yale New Haven Hospital (then Grace-New Haven) installed the first linear accelerator in Connecticut for cancer…
In 1959, William Prusoff of Yale University discovered idoxuridine, the first effective antiviral that fights herpes by interfering…
In 1954, John F. Enders, a native of West Hartford, Connecticut and a graduate of Yale University (B.A….
In 1953, Yale established the first pharmacology department in the U.S. to focus on cancer chemotherapy and cancer…